细胞学涂片二代测序检测肺腺癌临床相关变异的准确性
结果显示超过100个肿瘤细胞的涂片测序成功率显著高于少于100个者。
要点
- 涂片肿瘤细胞数超过100个时二代测序成功率更高。
- 巴氏涂片二代测序成功率有高于Diff-Quik涂片的趋势。
- 细胞学涂片可用于肺腺癌临床相关变异的分子检测。
核心结论
- 细胞学涂片肿瘤细胞数超过100个时二代测序成功可能性显著更高。
- 巴氏涂片较Diff-Quik涂片有更高的二代测序成功趋势。
研究设计与样本
- 纳入30例细胞学诊断且手术切除证实的原发性肺腺癌病例。
- 每例选取1张Diff-Quik染色涂片和1张巴氏染色涂片。
- 按肿瘤细胞数分为少于100个、100至500个、超过500个三组。
- 采用Ion Torrent平台进行二代测序。
主要发现
- 二代测序在所有细胞块及90%的涂片上成功完成。
- 配对的Diff-Quik与巴氏涂片细胞量相似,细胞量不同的病例差异在1个分组内。
- 超过100个肿瘤细胞的病例测序成功率为93%。
- 少于100个肿瘤细胞的病例测序成功率仅为67%。
- 二代测序为83%的Diff-Quik涂片和90%的巴氏涂片提供了临床相关信息。
临床怎么用
- 对肺腺癌细胞学涂片进行二代测序时,应确保肿瘤细胞数超过100个以提高成功率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Minimally invasive diagnostic procedures such as needle-core biopsy and fine-needle aspiration provide adequate material for molecular analyses. Advances in precision oncology are trending toward the interrogation of limited amounts of genomic material to guide clinical and therapeutic decisions. The aim of this study was to investigate the minimum cellularity needed on cytologic smears for the identification of clinically relevant variants with next-generation sequencing (NGS). METHODS: Thirty cases of cytologically diagnosed, resection-proven primary lung adenocarcinoma were identified. Nineteen of the 30 cases were known to harbor actionable variants. One Diff-Quik (DQ)-stained slide and 1 Papanicolaou (Pap)-stained slide were selected from each case. Cases were categorized as containing fewer than 100 tumor cells, 100 to 500 tumor cells, or more than 500 tumor cells. NGS was performed on the Ion Torrent platform. RESULTS: NGS was successfully performed on all cell blocks and on 90% of the smears. Paired DQ and Pap smears showed similar cellularity, and cases that differed in cellularity were within 1 category of each other. The cases with more than 100 tumor cells had a 93% success rate; this was significantly different from the situation for cases with fewer than 100 tumor cells, which were successfully sequenced only 67% of the time. Overall, NGS was able to provide clinically relevant information for 83% of DQ smears and for 90% of Pap smears tested. CONCLUSIONS: The data show a significantly higher likelihood of successful NGS with cytologic smears with more than 100 tumor cells. There was a trend for a higher NGS success rate with Pap smears versus DQ smears. Cancer Cytopathol 2017;125:398-406. © 2017 American Cancer Society.
引用
- Baum JE, Zhang P, Hoda RS, et al. Accuracy of next-generation sequencing for the identification of clinically relevant variants in cytology smears in lung adenocarcinoma. Cancer Cytopathol. 2017. PMID: 28272845. doi:10.1002/cncy.21844
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。